Advanced Micro Devices (NASDAQ:AMD) has given investors plenty to be concerned about, as its shares have continued their ...

We've been bemoaning the lack of progress in the design of iOS, with the iPhone software having looked pretty much the same ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...